
Join to view full profile
701 E El Camino RealMountain View, CA 94040
Phone+1 650-934-7676
Dr. Murase is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Residency, Dermatology, 2004 - 2007
Huntington Memorial HospitalInternship, Internal Medicine, 2003 - 2004
University of California, Irvine, School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2005 - 2027
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- Update on the status of women as editors in dermatology in 2024.Aleena Boby, Luiza R Pinto, Jenny E Murase, Jane M Grant-Kels, Nanette B Silverberg
International Journal of Women's Dermatology. 2026-10-01 - Mad fashion: Current regulations governing chemicals in clothing.Eryn Patin, Kathyana P Santiago Mangual, Jenny E Murase, Arianne Shadi Kourosh
Journal of the American Academy of Dermatology. 2026-07-01 - Bone health in women with hidradenitis suppurativa: addressing osteoporosis risks and management options.Gabriela E Beraja, Ana Maria Kausel, Jenny E Murase, Lindsey Bordone, Andrew Phillip Sawaya
International Journal of Women's Dermatology. 2026-06-01
Press Mentions
Managing Chronic Kidney Disease-Associated PruritusJuly 30th, 2025
Nemolizumab for Recalcitrant Pruritus: Targeting the ‘Itch Cytokine’July 25th, 2025
4-Phase Methodology Creates Rational and Effective Pathway to Control of Delusional DermatosesMarch 9th, 2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









